These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10880308)

  • 1. Prevalence and clinical significance of splenomegaly in asymptomatic human immunodeficiency virus type 1-infected adults. Swiss HIV cohort study.
    Furrer H
    Clin Infect Dis; 2000 Jun; 30(6):943-5. PubMed ID: 10880308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
    Badri M; Ehrlich R; Wood R; Pulerwitz T; Maartens G
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):225-32. PubMed ID: 11326821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators.
    Girard PM; Guiguet M; Bollens D; Goderel I; Meyohas MC; Lecomte I; Raguin G; Frottier J; Rozenbaum W; Jaillon P
    Clin Infect Dis; 2000 Oct; 31(4):987-94. PubMed ID: 11049781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
    Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
    J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of human immunodeficiency virus infection among adults in Mumbai.
    Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL
    Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of severe malaria in HIV-infected adults in South Africa.
    Cohen C; Karstaedt A; Frean J; Thomas J; Govender N; Prentice E; Dini L; Galpin J; Crewe-Brown H
    Clin Infect Dis; 2005 Dec; 41(11):1631-7. PubMed ID: 16267737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
    Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
    J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.
    Savès M; Chêne G; Ducimetière P; Leport C; Le Moal G; Amouyel P; Arveiler D; Ruidavets JB; Reynes J; Bingham A; Raffi F;
    Clin Infect Dis; 2003 Jul; 37(2):292-8. PubMed ID: 12856222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
    Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
    Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
    Goedert JJ;
    Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
    Mwanakasale V; Vounatsou P; Sukwa TY; Ziba M; Ernest A; Tanner M
    Am J Trop Med Hyg; 2003 Oct; 69(4):420-8. PubMed ID: 14640503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
    Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
    Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy.
    Archibald LK; McDonald LC; Nwanyanwu O; Kazembe P; Dobbie H; Tokars J; Reller LB; Jarvis WR
    J Infect Dis; 2000 Apr; 181(4):1414-20. PubMed ID: 10762572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy outcome in women infected with the human immunodeficiency virus].
    Figueroa-Damián R
    Salud Publica Mex; 1999; 41(5):362-7. PubMed ID: 11142830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.
    Laurent C; Bourgeois A; Faye MA; Mougnutou R; Seydi M; Gueye M; Liégeois F; Kane CT; Butel C; Mbuagbaw J; Zekeng L; Mboup S; Mpoudi-Ngolé E; Peeters M; Delaporte E
    J Infect Dis; 2002 Aug; 186(4):486-92. PubMed ID: 12195375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.